Sponsor
Bayer
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Bayer appears in 618 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownAn Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT TreatmentNCT07538843 · lead sponsor · 2026-07-31
RECRUITINGA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsNCT07330258 · lead sponsor · 2026-07-21
RECRUITINGA Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or DarolutamideNCT07672119 · lead sponsor · 2026-06-04
RECRUITINGA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionNCT07192952 · lead sponsor · 2026-06-01
RECRUITINGAn Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk ScoreNCT07554469 · lead sponsor · 2026-05-26
RECRUITINGA Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.NCT07450599 · lead sponsor · 2026-04-27
RECRUITINGHow Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in GermanyNCT07395804 · lead sponsor · 2026-04-14
RECRUITINGA Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South KoreaNCT07379840 · lead sponsor · 2025-12-23
RECRUITINGAn Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South KoreaNCT07232537 · lead sponsor · 2025-11-20
RECRUITINGA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionNCT07188805 · lead sponsor · 2025-11-19
RECRUITINGA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world SettingNCT07235462 · lead sponsor · 2025-10-29
RECRUITINGAn Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in AustraliaNCT07223372 · lead sponsor · 2025-10-10
RECRUITINGA Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology ClinicsNCT07406282 · lead sponsor · 2025-07-22
RECRUITINGA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsNCT06914128 · lead sponsor · 2025-03-21
RECRUITINGA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)NCT06760819 · lead sponsor · 2025-02-13
RECRUITINGA Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate CancerNCT06661122 · lead sponsor · 2024-11-18
RECRUITINGAn Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in KoreaNCT06334120 · lead sponsor · 2024-09-25
RECRUITINGA Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)NCT06452277 · lead sponsor · 2024-08-28
RECRUITINGAn Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsNCT06278207 · lead sponsor · 2024-05-15
RECRUITINGFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT06217822 · lead sponsor · 2024-03-07
RECRUITINGAn Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world SettingNCT06148935 · lead sponsor · 2023-11-30
RECRUITINGA Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world ConditionsNCT05666518 · lead sponsor · 2022-08-31
RECRUITINGA Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)NCT05348876 · lead sponsor · 2022-08-03
RECRUITINGFirst in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)NCT05099172 · lead sponsor · 2021-10-25
RECRUITINGStudy to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)NCT04519619 · lead sponsor · 2020-11-27
RECRUITINGA Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)NCT07566429 · lead sponsor · 2027-01-25
NOT_YET_RECRUITINGA Study of Darolutamide Plus Androgen Deprivation Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer in IndiaNCT07806591 · lead sponsor · 2026-10-15
NOT_YET_RECRUITINGA Study to Learn More About How Well Finerenone Works in Real-World in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)NCT07841015 · lead sponsor · 2026-09-30
NOT_YET_RECRUITINGA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical PracticeNCT07344779 · lead sponsor · 2026-01-29
ACTIVE_NOT_RECRUITINGAn Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical PracticeNCT06763146 · lead sponsor · 2025-09-22
ACTIVE_NOT_RECRUITINGAn Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World ConditionsNCT06632483 · lead sponsor · 2025-09-08
ACTIVE_NOT_RECRUITINGAn Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.NCT07124039 · lead sponsor · 2025-07-16
COMPLETEDAn Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical CareNCT06874114 · lead sponsor · 2025-02-28
COMPLETEDAn Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in JapanNCT06697353 · lead sponsor · 2024-11-01
COMPLETEDAn Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United StatesNCT06608212 · lead sponsor · 2024-10-09
COMPLETEDA Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood PressureNCT06428825 · lead sponsor · 2024-08-16
COMPLETEDAn Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical CareNCT06498921 · lead sponsor · 2024-07-15
COMPLETEDAn Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in GermanyNCT06486844 · lead sponsor · 2024-07-05
COMPLETEDA Study to Learn About the Taste of Vericiguat Given in Liquid Form in Healthy Male Participants Aged 18 to 45 YearsNCT06474208 · lead sponsor · 2024-07-01
COMPLETEDA Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection FractionNCT06195930 · lead sponsor · 2024-04-18
COMPLETEDA Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy ParticipantsNCT06360211 · lead sponsor · 2024-04-17
COMPLETEDA Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy ParticipantsNCT06348888 · lead sponsor · 2024-04-10
COMPLETEDAn Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United StatesNCT06363110 · lead sponsor · 2024-04-10
COMPLETEDA Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy ParticipantsNCT06378658 · lead sponsor · 2024-03-29
COMPLETEDA Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy ParticipantsNCT06329895 · lead sponsor · 2024-03-25
COMPLETEDAn Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and SwedenNCT06053749 · lead sponsor · 2024-03-20
ACTIVE_NOT_RECRUITINGA Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 DiabetesNCT05901831 · lead sponsor · 2024-02-26
COMPLETEDA Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male ParticipantsNCT06221475 · lead sponsor · 2024-01-25
COMPLETEDAn Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United StatesNCT06204302 · lead sponsor · 2024-01-05
COMPLETEDA Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate CancerNCT06010914 · lead sponsor · 2023-10-09
ACTIVE_NOT_RECRUITINGA Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT06052306 · lead sponsor · 2023-09-20
ACTIVE_NOT_RECRUITINGA Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)NCT06048120 · lead sponsor · 2023-09-15
COMPLETEDAn Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World SettingsNCT06013475 · lead sponsor · 2023-08-31
COMPLETEDA Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus PatientsNCT05552339 · lead sponsor · 2023-08-18
COMPLETEDA First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid TumorsNCT05858164 · lead sponsor · 2023-08-07
COMPLETEDThe VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection FractionNCT05974189 · lead sponsor · 2023-07-11
COMPLETEDAn Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsNCT05703880 · lead sponsor · 2023-06-01
COMPLETEDA Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male ParticipantsNCT07116512 · lead sponsor · 2023-05-02
COMPLETEDAn Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in ChinaNCT05728502 · lead sponsor · 2023-04-25
COMPLETEDA Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesNCT05794906 · lead sponsor · 2023-04-03
ACTIVE_NOT_RECRUITINGSponsor roles
lead sponsor412
collaborator206
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.